CLINICAL_TRIALS
trial_result
· 2009-06-02
Clinical Trial Update: Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate [Phase 2]
Summary
This Phase 2 trial of natalizumab for rheumatoid arthritis in patients on methotrexate was terminated, with results posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2009-06-02